Biologic medicines are fundamentally different from traditional “small molecule” therapies, presenting a host of new challenges in the design and enforcement of the intellectual property (IP) architecture that will protect them. Protecting the intellectual property of biologics is complicated, difficult, and essential to the future of medicine. This new frontier is also one of the remaining hurdles in the Trans-Pacific Partnership (TPP) Trade Agreement negotiations. The debate over protecting biologics focuses on a proposed twelve years of data exclusivity and the consequences this will have for international trade, global public health, and access to medicines.
The nuances of producing biologics greatly complicate the logistics of protecting their intellectual property, making patents alone inadequate for safeguarding their IP. Data exclusivity protection allows for a period of time following marketing approval during which competing firms may not use the innovative firm’s safety and efficacy data, from proprietary preclinical and clinical trial results, to obtain marketing authorization for a generic version of the drug. From the moment when the compound first shows medicinal promise, data is generated and compiled, a process that is both expensive and time consuming. Data exclusivity provides the innovative firm with a period of protection for their investment in clinical trials and data collection, regardless of the length of time required to bring the drug to market.
In the patent world, Musk has been creating some waves in his role as CEO of Tesla Motors. In a self-authored blog post published on the official Tesla Motors blog, Musk announced that the company was trying to make the company ‘open source’ by allowing other people to infringe on their patent portfolio with the supposed intent of encouraging the development of electric vehicle technologies. Interestingly to us, his comments in the post, titled “All Our Patent Are Belong To You” and published on June 12, explain: ” Tesla will not initiate patent lawsuits against anyone who, in good faith, wants to use our technology.” But who is to decide if one is acting in “good faith”?
IPWatchdog is always interested in covering the world’s most innovative business entities in the Companies We Follow series. Today, we take a glance at the many inventions and innovations being researched and developed by this major automobile manufacturer. The patent applications filed by Toyota with the U.S. Patent and Trademark Office detail an interesting future in vehicle development for this Japanese multinational corporation and its subsidiaries. We also take a close look at many recently issued patents to see Toyota’s standing in the world of intellectual property protection.
Today’s featured application discusses a system designed to better provide warning information to drivers without distracting a driver or displaying redundant information on multiple screens. This system would also ensure that drivers receive the warning message even if the heads-up display or another screen is malfunctioning. Navigational systems for self-driving cars are described in another couple of patent applications which we discovered, as well as some inventions related to hybrid electric or hydrogen-powered vehicles.
* Job Title / Position: Patent Prosecution Associate * Job Location: San Francisco
The San Francisco office of Morgan Lewis & Bockius, LLP an international law firm with some 1,400 attorneys, seeks a highly motivated, junior to mid-level associate for our Intellectual Property Practice.
The ideal candidates must have patent prosecution experience in the fields of life sciences, preferably with an advanced degree in biochemistry, biomedical engineering, molecular biology, immunology, and/or biology. Candidates must possess excellent academic credentials and strong research, writing, communication, interpersonal, and organizational skills. Candidates must be registered with the U.S. Patent and Trademark Office and a member of the California bar.
Patent terminology can be daunting at times, making it quite unapproachable for a novice inventor to understand what is really going on and what options are available in terms of filing a patent application. Take for example the various types of national patent applications that one can file. A national patent application means a U.S. application for patent that was either filed in the Patent Office under 35 U.S.C. 111 (i.e., directly with the USPTO as a domestic U.S. patent application), or which entered the national stage from an international patent application after compliance with 35 U.S.C. 371 (i.e., initially filed as an international application invoking the benefits of the Patent Cooperation Treaty).
Although these may be difficult days for GM, here at IPWatchdog we understand that the amount and frequency of patenting activities undertaken by this corporation makes it impossible to skip them for our Companies We Follow series. As usual, we’re seeing a lot of patent applications and issued patents assigned to this corporation from the U.S. Patent and Trademark Office, and almost all of them are directed at vehicular technologies. Today, we discuss a collection of inventions which we feel offer up a good representation of the technologies being developed for the next generation of cars, trucks and more.
Telematics systems are the focus of a number of patent applications which we delve into today, including today’s featured application, which uses on-board telematics to transmit important automobile information to a central facility. The system is capable of sending more data than previous systems by routing the data through a wireless mobile device used by the driver, reducing the cost of data transmission from the vehicle. Improved speech recognition for on-board computer system controls and a steering wheel light system designed to refocus a driver’s attention onto the road are also discussed.
HORSHAM, Pa., July 1, 2014— Reed Technology and Information Services Inc., a LexisNexis company, today announced an agreement to acquire PatentCore, the Minneapolis-based developer of the LexisNexis® PatentAdvisorSM solution suite. The acquisition will enhance the LexisNexis intellectual property (IP) offerings and give customers access to a broader range of innovative and unique IP services.
“Our relationship with PatentCore has helped us integrate more dynamic patent analytics capabilities into a strong base of IP products and services available through LexisNexis,” said Samuel Hardman, President of Reed Tech. “PatentAdvisor offers highly valuable analytical and statistical insights on patent prosecution and portfolio management that are unique in the marketplace.”
PatentAdvisor is a suite of easy-to-use, web-based patent analytics tools that make patent prosecution a more strategic and predictable process for IP-driven companies and law firms. The suite leverages mature big data sets and analytics, delivering searchable and actionable information to drive more effective and efficient patent prosecution and management.
IPWatchdog’s Companies We Follow series always tries to pay close attention to the intellectual property activities of the world’s largest consumer electronics developers. Microsoft’s investment into research and development for computing technologies results in a large number of patent filings registered at the U.S. Patent and Trademark Office. We return once again to focus on patent applications and recently issued patents assigned to Microsoft to provide an interesting look into this corporation’s innovations for our readers.
The featured patent application which we’ve chosen for today’s column discusses a social networking method which tries to enhance the shared viewing of video content among a group of people in geographically diverse locations. The movie theater interface gives group members the opportunity to communicate thoughts and emotions with others watching the same content. More intelligent computing systems for task management and advertising video games for download are also described within recently filed patent applications.